{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:38:31Z","timestamp":1791301111304,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:00:00Z","timestamp":1509580800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00392-017-1165-3","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T03:04:20Z","timestamp":1509591860000},"page":"138-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart"],"prefix":"10.1007","volume":"107","author":[{"given":"Rasmus","family":"Rivinius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Helmschrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjang","family":"Ruhparwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Rahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice F.","family":"Darche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dierk","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bruckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Ehlermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo A.","family":"Katus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas O.","family":"Doesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,2]]},"reference":[{"issue":"9744","key":"1165_CR1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744):875\u2013885","journal-title":"Lancet"},{"issue":"9744","key":"1165_CR2","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","volume":"376","author":"M B\u00f6hm","year":"2010","unstructured":"B\u00f6hm M, Swedberg K, Komajda M et al (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376(9744):886\u2013894","journal-title":"Lancet"},{"issue":"7","key":"1165_CR3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00392-015-0956-7","volume":"105","author":"F Custodis","year":"2016","unstructured":"Custodis F, Roggenbuck U, Lehmann N et al (2016) Resting heart rate is an independent predictor of all-cause mortality in the middle aged general population. Clin Res Cardiol 105(7):601\u2013612","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"1165_CR4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s00392-015-0873-9","volume":"104","author":"BN Schaeffer","year":"2015","unstructured":"Schaeffer BN, Rybczynski M, Sheikhzadeh S et al (2015) Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome. Clin Res Cardiol 104(12):1054\u20131063","journal-title":"Clin Res Cardiol"},{"key":"1165_CR5","doi-asserted-by":"crossref","unstructured":"Eick C, Duckheim M, Groga-Bada P et al (2017) Point-of-care testing of cardiac autonomic function for risk assessment in patients with suspected acute coronary syndromes. Clin Res Cardiol 106(9):686\u2013694","DOI":"10.1007\/s00392-017-1104-3"},{"issue":"11","key":"1165_CR6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00392-008-0690-5","volume":"97","author":"R Zhang","year":"2008","unstructured":"Zhang R, Haverich A, Str\u00fcber M, Simon A, Pichlmaier M, Bara C (2008) Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia. Clin Res Cardiol 97(11):811\u2013819","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"1165_CR7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00392-012-0436-2","volume":"101","author":"R Zhang","year":"2012","unstructured":"Zhang R, Bobylev D, Stiefel P, Haverich A, Bara C (2012) Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study. Clin Res Cardiol 101(8):631\u2013636","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"1165_CR8","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/01.tp.0000285265.86954.80","volume":"84","author":"AO Doesch","year":"2007","unstructured":"Doesch AO, Celik S, Ehlermann P et al (2007) Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine. Transplantation 84(8):988\u2013996","journal-title":"Transplantation"},{"issue":"6","key":"1165_CR9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/TP.0b013e3181b4e0f5","volume":"88","author":"AO Doesch","year":"2009","unstructured":"Doesch AO, Ammon K, Konstandin M et al (2009) Heart rate reduction for 12\u00a0months with ivabradine reduces left ventricular mass in cardiac allograft recipients. Transplantation 88(6):835\u2013841","journal-title":"Transplantation"},{"key":"1165_CR10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2147\/DDDT.S53705","volume":"7","author":"AO Doesch","year":"2013","unstructured":"Doesch AO, Mueller S, Erbel C et al (2013) Heart rate reduction for 36\u00a0months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study. Drug Des Dev Ther 7:1323\u20131328","journal-title":"Drug Des Dev Ther"},{"issue":"1 Pt 3","key":"1165_CR11","first-page":"2506","volume":"19","author":"S Sch\u00fcler","year":"1987","unstructured":"Sch\u00fcler S, Thomas D, Thebken M, Frei U, Wagner T, Warnecke H, Hetzer R (1987) Endocrine response to exercise in cardiac transplant patients. Transplant Proc 19(1 Pt 3):2506\u20132509","journal-title":"Transplant Proc"},{"issue":"10","key":"1165_CR12","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/01.TP.0000141093.04132.41","volume":"78","author":"F Beckers","year":"2004","unstructured":"Beckers F, Ramaekers D, Speijer G et al (2004) Different evolutions in heart rate variability after heart transplantation: 10-year follow-up. Transplantation 78(10):1523\u20131531","journal-title":"Transplantation"},{"issue":"2","key":"1165_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0002-9149(96)90592-5","volume":"77","author":"I Halpert","year":"1996","unstructured":"Halpert I, Goldberg AD, Levine AB, Levine TB, Kornberg R, Kelly C, Lesch M (1996) Reinnervation of the transplanted human heart as evidenced from heart rate variability studies. Am J Cardiol 77(2):180\u2013183","journal-title":"Am J Cardiol"},{"issue":"6","key":"1165_CR14","first-page":"621","volume":"16","author":"J Koglin","year":"1997","unstructured":"Koglin J, Gross T, Uberfuhr P, von Scheidt W (1997) Time-dependent decrease of presynaptic inotropic supersensitivity: physiological evidence of sympathetic reinnervation after heart transplantation. J Heart Lung Transplant 16(6):621\u2013628","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"1165_CR15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S1053-2498(99)00048-0","volume":"18","author":"M Schwaiblmair","year":"1999","unstructured":"Schwaiblmair M, von Scheidt W, Uberfuhr P, Ziegler S, Schwaiger M, Reichart B, Vogelmeier C (1999) Functional significance of cardiac reinnervation in heart transplant recipients. J Heart Lung Transplant 18(9):838\u2013845","journal-title":"J Heart Lung Transplant"},{"issue":"10","key":"1165_CR16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa010519","volume":"345","author":"FM Bengel","year":"2001","unstructured":"Bengel FM, Ueberfuhr P, Schiepel N, Nekolla SG, Reichart B, Schwaiger M (2001) Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med 345(10):731\u2013738","journal-title":"N Engl J Med"},{"issue":"4","key":"1165_CR17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/eurheartj\/14.4.530","volume":"14","author":"CD Scott","year":"1993","unstructured":"Scott CD, McComb JM, Dark JH (1993) Heart rate and late mortality in cardiac transplant recipients. Eur Heart J 14(4):530\u2013533","journal-title":"Eur Heart J"},{"issue":"1","key":"1165_CR18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/eurjhf\/hft129","volume":"16","author":"D Dobre","year":"2014","unstructured":"Dobre D, Borer JS, Fox K et al (2014) Heart rate: a prognostic factor and therapeutic target in chronic heart failure. The distinct roles of drugs with heart rate-lowering properties. Eur J Heart Fail 16(1):76\u201385","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"1165_CR19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00392-014-0778-z","volume":"104","author":"J Li","year":"2015","unstructured":"Li J, Franke J, Pribe-Wolferts R et al (2015) Effects of \u03b2-blocker therapy on electrocardiographic and echocardiographic characteristics of left ventricular noncompaction. Clin Res Cardiol 104(3):241\u2013249","journal-title":"Clin Res Cardiol"},{"issue":"23","key":"1165_CR20","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","volume":"26","author":"JC Tardif","year":"2005","unstructured":"Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K, INITIATIVE Investigators (2005) Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 26(23):2529\u20132536","journal-title":"Eur Heart J"},{"issue":"12","key":"1165_CR21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00392-016-1014-9","volume":"105","author":"\u00d2 Mir\u00f3","year":"2016","unstructured":"Mir\u00f3 \u00d2, M\u00fcller C, Mart\u00edn-S\u00e1nchez FJ et al (2016) BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure. Clin Res Cardiol 105(12):1021\u20131029","journal-title":"Clin Res Cardiol"},{"issue":"6096","key":"1165_CR22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/324470a0","volume":"324","author":"D DiFrancesco","year":"1986","unstructured":"DiFrancesco D (1986) Characterization of single pacemaker channels in cardiac sino-atrial node cells. Nature 324(6096):470\u2013473","journal-title":"Nature"},{"key":"1165_CR23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/jphysiol.1991.sp018457","volume":"434","author":"D DiFrancesco","year":"1991","unstructured":"DiFrancesco D (1991) The contribution of the \u2018pacemaker\u2019 current (if) to generation of spontaneous activity in rabbit sino-atrial node myocytes. J Physiol 434:23\u201340","journal-title":"J Physiol"},{"issue":"16","key":"1165_CR24","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2165\/00003495-200464160-00003","volume":"64","author":"D DiFrancesco","year":"2004","unstructured":"DiFrancesco D, Camm JA (2004) Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 64(16):1757\u20131765","journal-title":"Drugs"},{"issue":"1","key":"1165_CR25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.bjp.0706940","volume":"150","author":"C Thollon","year":"2007","unstructured":"Thollon C, Bedut S, Villeneuve N et al (2007) Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity. Br J Pharmacol 150(1):37\u201346","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1165_CR26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00392-015-0950-0","volume":"105","author":"U Fischer-Rasokat","year":"2016","unstructured":"Fischer-Rasokat U, Honold J, Lochmann D et al (2016) \u03b2-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index. Clin Res Cardiol 105(6):527\u2013534","journal-title":"Clin Res Cardiol"},{"issue":"13","key":"1165_CR27","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/01.CIR.0000118464.48959.1C","volume":"109","author":"P Mulder","year":"2004","unstructured":"Mulder P, Barbier S, Chagraoui A et al (2004) Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109(13):1674\u20131679","journal-title":"Circulation"},{"issue":"7","key":"1165_CR28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ehj.2003.10.010","volume":"25","author":"X Monnet","year":"2004","unstructured":"Monnet X, Colin P, Ghaleh B, Hittinger L, Giudicelli JF, Berdeaux A (2004) Heart rate reduction during exercise-induced myocardial ischaemia and stunning. Eur Heart J 25(7):579\u2013586","journal-title":"Eur Heart J"},{"key":"1165_CR29","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2147\/DDDT.S136948","volume":"11","author":"R Rivinius","year":"2017","unstructured":"Rivinius R, Helmschrott M, Ruhparwar A et al (2017) Comparison of post-transplant outcomes in patients with no, acute or chronic amiodarone use before heart transplantation. Drug Des Dev Ther 11:1827\u20131837","journal-title":"Drug Des Dev Ther"},{"key":"1165_CR30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/TCRM.S126869","volume":"13","author":"R Rivinius","year":"2017","unstructured":"Rivinius R, Helmschrott M, Ruhparwar A et al (2017) The influence of surgical technique on early posttransplant atrial fibrillation\u2014comparison of biatrial, bicaval, and total orthotopic heart transplantation. Ther Clin Risk Manag 13:287\u2013297","journal-title":"Ther Clin Risk Manag"},{"key":"1165_CR31","first-page":"677","volume":"10","author":"R Rivinius","year":"2016","unstructured":"Rivinius R, Helmschrott M, Ruhparwar A et al (2016) Long-term use of amiodarone before heart transplantation reduces significantly early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation. Drug Des Dev Ther 10:677\u2013686","journal-title":"Drug Des Dev Ther"},{"key":"1165_CR32","first-page":"93","volume":"9","author":"R Rivinius","year":"2014","unstructured":"Rivinius R, Helmschrott M, Ruhparwar A et al (2014) Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy. Drug Des Dev Ther 9:93\u2013102","journal-title":"Drug Des Dev Ther"},{"key":"1165_CR33","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2147\/DDDT.S135503","volume":"11","author":"M Helmschrott","year":"2017","unstructured":"Helmschrott M, Rivinius R, Bruckner T, Katus HA, Doesch AO (2017) Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy. Drug Des Dev Ther 11:1673\u20131680","journal-title":"Drug Des Dev Ther"},{"key":"1165_CR34","first-page":"1217","volume":"9","author":"M Helmschrott","year":"2015","unstructured":"Helmschrott M, Rivinius R, Ruhparwar A et al (2015) Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation. Drug Des Dev Ther 9:1217\u20131224","journal-title":"Drug Des Dev Ther"},{"issue":"10","key":"1165_CR35","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00392-016-1013-x","volume":"105","author":"T Doenst","year":"2016","unstructured":"Doenst T, Str\u00fcning C, Moschovas A et al (2016) Cardiac surgery 2015 reviewed. Clin Res Cardiol 105(10):801\u2013814","journal-title":"Clin Res Cardiol"},{"key":"1165_CR36","doi-asserted-by":"crossref","unstructured":"Doenst T, Essa Y, Jacoub K et al (2017) Cardiac surgery 2016 reviewed. Clin Res Cardiol 106(11):851\u2013867","DOI":"10.1007\/s00392-017-1113-2"},{"issue":"1","key":"1165_CR37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchf.2013.09.005","volume":"2","author":"RM Reed","year":"2014","unstructured":"Reed RM, Netzer G, Hunsicker L, Mitchell BD, Rajagopal K, Scharf S, Eberlein M (2014) Cardiac size and sex-matching in heart transplantation: size matters in matters of sex and the heart. JACC Heart Fail 2(1):73\u201383","journal-title":"JACC Heart Fail"},{"issue":"1","key":"1165_CR38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/01.CIR.60.1.164","volume":"60","author":"H Boudoulas","year":"1979","unstructured":"Boudoulas H, Rittgers SE, Lewis RP, Leier CV, Weissler AM (1979) Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion. Circulation 60(1):164\u2013169","journal-title":"Circulation"},{"issue":"3","key":"1165_CR39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.CIR.75.3.661","volume":"75","author":"BD Guth","year":"1987","unstructured":"Guth BD, Heusch G, Seitelberger R, Ross J Jr (1987) Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis. Circulation 75(3):661\u2013669","journal-title":"Circulation"},{"issue":"Suppl L","key":"1165_CR40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/eurheartj\/8.suppl_L.115","volume":"8","author":"J Kjekshus","year":"1987","unstructured":"Kjekshus J (1987) Heart rate reduction\u2014a mechanism of benefit? Eur Heart J 8(Suppl L):115\u2013122","journal-title":"Eur Heart J"},{"issue":"4","key":"1165_CR41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00045415-199907000-00011","volume":"7","author":"SR Kapadia","year":"1999","unstructured":"Kapadia SR (1999) Cytokines and heart failure. Cardiol Rev 7(4):196\u2013206","journal-title":"Cardiol Rev"},{"issue":"2","key":"1165_CR42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/01.RES.86.2.152","volume":"86","author":"T Ide","year":"2000","unstructured":"Ide T, Tsutsui H, Kinugawa S et al (2000) Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 86(2):152\u2013157","journal-title":"Circ Res"},{"issue":"5","key":"1165_CR43","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jtcvs.2007.05.037","volume":"134","author":"M Schnoor","year":"2007","unstructured":"Schnoor M, Sch\u00e4fer T, L\u00fchmann D, Sievers HH (2007) Bicaval versus standard technique in orthotopic heart transplantation: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 134(5):1322\u20131331","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"1165_CR44","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1590\/S0066-782X2010000600018","volume":"94","author":"RF Locali","year":"2010","unstructured":"Locali RF, Matsuoka PK, Cherbo T, Gabriel EA, Buffolo E (2010) Should biatrial heart transplantation still be performed?: a meta-analysis. Arq Bras Cardiol 94(6):829\u2013840","journal-title":"Arq Bras Cardiol"},{"issue":"11","key":"1165_CR45","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0002-9149(00)00765-7","volume":"85","author":"AM Grande","year":"2000","unstructured":"Grande AM, Rinaldi M, D\u2019Armini AM et al (2000) Orthotopic heart transplantation: standard versus bicaval technique. Am J Cardiol 85(11):1329\u20131333","journal-title":"Am J Cardiol"},{"issue":"2","key":"1165_CR46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.healun.2007.11.003","volume":"27","author":"ES Weiss","year":"2008","unstructured":"Weiss ES, Nwakanma LU, Russell SB, Conte JV, Shah AS (2008) Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database. J Heart Lung Transplant 27(2):178\u2013183","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"1165_CR47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/icvts\/ivr084","volume":"14","author":"AM Dell\u2019Aquila","year":"2012","unstructured":"Dell\u2019Aquila AM, Mastrobuoni S, Bastarrika G et al (2012) Bicaval versus standard technique in orthotopic heart transplant: assessment of atrial performance at magnetic resonance and transthoracic echocardiography. Interact Cardiovasc Thorac Surg 14(4):457\u2013462","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"6","key":"1165_CR48","first-page":"2677","volume":"24","author":"W Konertz","year":"1992","unstructured":"Konertz W, Weyand M, Deiwick M, Scheld HH (1992) Is pretransplant antiarrhythmic drug therapy a risk factor? Transplant Proc 24(6):2677\u20132678","journal-title":"Transplant Proc"},{"issue":"3","key":"1165_CR49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.amjcard.2003.10.027","volume":"93","author":"PJ Blomberg","year":"2004","unstructured":"Blomberg PJ, Feingold AD, Denofrio D et al (2004) Comparison of survival and other complications after heart transplantation in patients taking amiodarone before surgery versus those not taking amiodarone. Am J Cardiol 93(3):379\u2013381","journal-title":"Am J Cardiol"},{"issue":"4","key":"1165_CR50","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/j.healun.2014.01.314","volume":"33","author":"H Yerebakan","year":"2014","unstructured":"Yerebakan H, Naka Y, Sorabella R et al (2014) Amiodarone treatment prior to heart transplantation is associated with acute graft dysfunction and early mortality: a propensity-matched comparison. J Heart Lung Transplant 33(4):S105","journal-title":"J Heart Lung Transplant"},{"key":"1165_CR51","first-page":"743","volume":"10","author":"P Macdonald","year":"1991","unstructured":"Macdonald P, Hackworthy R, Keogh A, Sivathasan C, Chang V, Spratt P (1991) The effect of chronic amiodarone therapy before transplantation on early cardiac allograft function. J Heart Lung Transplant 10:743\u2013749","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"1165_CR52","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/0735-1097(92)90450-2","volume":"20","author":"C Chelimsky-Fallick","year":"1992","unstructured":"Chelimsky-Fallick C, Middlekauff HR, Stevenson WG et al (1992) Amiodarone therapy does not compromise subsequent heart transplantation. J Am Coll Cardiol 20(7):1556\u20131561","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1165_CR53","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.transproceed.2006.08.022","volume":"38","author":"IJ Sanchez-Lazaro","year":"2006","unstructured":"Sanchez-Lazaro IJ, Almenar L, Martinez-Dolz L et al (2006) Does amiodarone influence early mortality in heart transplantation? Transplant Proc 38(8):2537\u20132538","journal-title":"Transplant Proc"},{"issue":"6","key":"1165_CR54","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00395-011-0227-3","volume":"106","author":"S Kr\u00f6ller-Sch\u00f6n","year":"2011","unstructured":"Kr\u00f6ller-Sch\u00f6n S, Schulz E, Wenzel P et al (2011) Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress. Basic Res Cardiol 106(6):1147\u20131158","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"1165_CR55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00392-016-1024-7","volume":"106","author":"F Mangiacapra","year":"2017","unstructured":"Mangiacapra F, Colaiori I, Ricottini E et al (2017) Heart rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study. Clin Res Cardiol 106(1):69\u201375","journal-title":"Clin Res Cardiol"},{"key":"1165_CR56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ehf2.12013","volume":"1","author":"HN Sabbah","year":"2014","unstructured":"Sabbah HN, Gupta RC, Kohli S, Wang M, Zhang K, Sharad R (2014) Heart rate reduction with ivabradine improves left ventricular function and reverses multiple pathological maladaptations in dogs with chronic heart failure. ESC Heart Fail 1:94\u2013102","journal-title":"ESC Heart Fail"},{"key":"1165_CR57","doi-asserted-by":"crossref","unstructured":"Fr\u00f6hlich H, Torres L, T\u00e4ger T et al (2017) Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure. Clin Res Cardiol 106(9):711\u2013721","DOI":"10.1007\/s00392-017-1115-0"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-017-1165-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-017-1165-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-017-1165-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T09:06:43Z","timestamp":1517303203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-017-1165-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1007\/s00392-017-1165-3","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]}}}